DECEMBER 8, 2023

FDA Approves First Gene Therapies to Treat Patients With Sickle Cell Disease

By PPN Staff

The FDA approved the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients aged 12 years and older.

To read the full story, Log in or Sign up for a Free Account

First Name

Last Name

Organization/Institution

State

NPI	Name	Organization/ Institution	State	Zip Code	Taxonomy	Credential	Select